RINVOQ 45 mg prolonged-release tablets | medicines.ie

Company: AbbVie Limited
Active Ingredient: Upadacitinib
Dosage Form: Prolonged-release tablet
Legal Category: A - prescription, may not be renewed

*further information is available on request to the holder of the authorisation or in the SPC

Licence numbers with strength, ATC code and dosage form
Licence number	Strength	ATC Code	Dosage Form
EU/1/19/1404/0010	45 milligram (s)	L04AF03	Prolonged-release tablet

Licence number: EU/1/19/1404/0010
Strength: 45 milligram (s)
ATC Code: L04AF03
Dosage Form: Prolonged-release tablet

AbbVie Limited

Citywest Business Campus, Dublin 24, Ireland